ICUCW — SeaStar Medical Holding Corp
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1831868 ·
Last close
—
Market Cap
—
52W High
—
52W Low
—
ADV30
—
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 615,000 | 561,000 | -3,791,000 | -3,730,000 | 8,649,000 | 6,959,000 | 4,353,000 |
| Mar 2026 | 495,000 | 449,000 | -3,603,000 | -3,521,000 | 11,263,000 | 9,348,000 | 3,948,000 |
| Dec 2025 | 420,000 | 408,000 | -3,016,000 | -2,904,000 | 14,158,000 | 11,980,000 | 3,742,000 |
| Sep 2025 | 183,000 | 169,000 | -3,579,000 | -3,472,000 | 15,530,000 | 13,763,000 | 4,066,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-13,706,000
Investing CF
—
Financing CF
$17,758,000
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
—
As of
2026-08-16
Balance + Analyst (yfinance extras)
Retained Earnings
$-155,235,000
Inventory
$57,000
Receivables
$179,000
ST Investments
—
EBIT TTM
$-11,868,000
Pretax Income TTM
$-11,896,000
Interest Exp TTM
$28,000
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$1,713,000
EBITDA
—
Free Cash Flow
$-9,141,000
Enterprise Value
—
Total Cash
$6,959,000
Total Debt
$134,000
Shares Out
—
Trailing EPS
—
Book Value
$1.01
ROE
-356.9%
ROA
-102.7%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 1,234,000 | -12,175,000 | -12,150,000 | 14,158,000 | 3,742,000 | 10,416,000 | -13,599,000 |
| Dec 2024 | 135,000 | -17,842,000 | -24,830,000 | 4,658,000 | 6,841,000 | -2,183,000 | -16,007,000 |
| Dec 2023 | 0 | -14,210,000 | -26,232,000 | 3,513,000 | 17,383,000 | -13,870,000 | -10,285,000 |
| Dec 2022 | 0 | -11,609,000 | -12,190,000 | 3,038,000 | 23,800,000 | -20,762,000 | -7,794,000 |
TTM Snapshot
Revenues TTM
$1,436,000
NetIncome TTM
$-11,899,000
OpCashFlow TTM
—
Assets (Latest)
$11,263,000
Forward EPS
—
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| ISRG | INTUITIVE SURGICAL INC | $151.90B | $423.96 | — |
| MDT | Medtronic plc | $113.18B | $88.48 | — |
| SYK | STRYKER CORP | $106.38B | $277.33 | — |
| MMM | 3M CO | $82.49B | $159.96 | — |
| BSX | BOSTON SCIENTIFIC CORP | $61.93B | $42.73 | — |
News headlines (Yahoo Finance, 1h cache)
FDA Grants SeaStar Medical Breakthrough Device Designation for its SCD Therapy for the Treatment of Hyperinflammation in Adult Patients with Sepsis or a Septic Condition
2026-10-07 12:16 · Yahoo
SeaStar Medical Announces Exercise of Warrants for Approximately $3.3 Million Gross Proceeds
2026-10-05 12:00 · Yahoo
SeaStar Medical Announces Late-Breaking Presentation at ASN Kidney Week 2026
2026-10-02 13:43 · Yahoo
New ICD-10-PCS Codes are Now Available for the Use of SeaStar Medical’s SCD Therapy for Acute Kidney Injury (AKI)
2026-10-01 12:21 · Yahoo
SeaStar Medical Announces Chief Medical Officer, Kevin Chung, M.D., to Present at the Pediatric Paracorporeal and Extracorporeal Therapy Symposium (PPETS) 2026
2026-09-29 12:36 · Yahoo
SeaStar Medical Congratulates H. David Humes, M.D., on Receiving the University of Michigan 2026 Distinguished University Innovator of the Year for Development of the SCD Therapy
2026-09-24 12:16 · Yahoo
SeaStar Medical to Present at the HC Wainwright 28th Annual Global Investment Conference
2026-09-10 12:35 · Yahoo
ICU: Continued Revenue Growth for QUELIMMUNE®
2026-08-17 13:12 · Yahoo
SeaStar Medical Holding Corp (ICU) (Q2 2026) Earnings Call Highlights: Qualimmune Revenue ...
2026-08-13 05:02 · Yahoo
SeaStar Medical (ICU) Q2 2026 Earnings Call Transcript
2026-08-13 01:43 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.